Literature DB >> 25732901

Burden of Serious Infections in Adults With Systemic Lupus Erythematosus: A National Population-Based Study, 1996-2011.

Maria G Tektonidou1, Zhong Wang2, Abhijit Dasgupta2, Michael M Ward2.   

Abstract

OBJECTIVE: To compare rates of hospitalization for serious infections, trends in rates from 1996 to 2011, and in-hospital mortality between patients with systemic lupus erythematosus (SLE) and those without SLE in a national sample.
METHODS: We analyzed hospitalizations for pneumonia, bacteremia/sepsis, urinary tract infections, skin infections, and opportunistic infections among adults in the Nationwide Inpatient Sample. We compared rates of hospitalization yearly among patients with SLE and the general population. We also computed odds ratios (ORs) for in-hospital mortality.
RESULTS: In 1996, the estimated number of hospitalizations for pneumonia in patients with SLE was 4,382, followed by sepsis (2,305), skin infections (1,422), urinary tract infections (643), and opportunistic infections (370). Rates were much higher in patients with SLE than in those without SLE, with age-adjusted relative risks ranging from 5.7 (95% confidence interval [95% CI] 5.5-6.0) for pneumonia to 9.8 (95% CI 9.1-10.7) for urinary tract infection in 1996. Risks increased over time, so that by 2011, all relative risks exceeded 12.0. Overall risk of in-hospital mortality was higher in SLE only for opportunistic infections (adjusted OR 1.52 [95% CI 1.12-2.07]). However, in pneumonia and sepsis, mortality risks were higher in SLE among those who required mechanical ventilation.
CONCLUSION: Hospitalization rates for serious infections in SLE increased substantially between 1996 and 2011, reaching over 12 times higher than in patients without SLE in 2011. Reasons for this acceleration are unclear. In-hospital mortality was higher among patients with SLE and opportunistic infections and those with pneumonia or sepsis who required mechanical ventilation.
© 2015, American College of Rheumatology.

Entities:  

Mesh:

Year:  2015        PMID: 25732901      PMCID: PMC4516647          DOI: 10.1002/acr.22575

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  44 in total

1.  A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data.

Authors:  Carl van Walraven; Peter C Austin; Alison Jennings; Hude Quan; Alan J Forster
Journal:  Med Care       Date:  2009-06       Impact factor: 2.983

2.  The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis.

Authors:  Mitchell M Levy; R Phillip Dellinger; Sean R Townsend; Walter T Linde-Zwirble; John C Marshall; Julian Bion; Christa Schorr; Antonio Artigas; Graham Ramsay; Richard Beale; Margaret M Parker; Herwig Gerlach; Konrad Reinhart; Eliezer Silva; Maurene Harvey; Susan Regan; Derek C Angus
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

3.  Strategies in immunosuppression after heart transplantation: is less better?

Authors:  Jon A Kobashigawa
Journal:  Circ Heart Fail       Date:  2011-03       Impact factor: 8.790

4.  Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009.

Authors:  Peter K Lindenauer; Tara Lagu; Meng-Shiou Shieh; Penelope S Pekow; Michael B Rothberg
Journal:  JAMA       Date:  2012-04-04       Impact factor: 56.272

Review 5.  Infections in the lupus patient: perspectives on prevention.

Authors:  Claire Barber; Wayne L Gold; Paul R Fortin
Journal:  Curr Opin Rheumatol       Date:  2011-07       Impact factor: 5.006

6.  Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s.

Authors:  Anselm Mak; Mike W-L Cheung; Hui Jin Chiew; Yang Liu; Roger Chun-man Ho
Journal:  Semin Arthritis Rheum       Date:  2012-01-16       Impact factor: 5.532

7.  Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus.

Authors:  J E Navarro-Zarza; E Alvarez-Hernández; J C Casasola-Vargas; E Estrada-Castro; R Burgos-Vargas
Journal:  Lupus       Date:  2009-11-02       Impact factor: 2.911

8.  European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies.

Authors:  M Mosca; C Tani; M Aringer; S Bombardieri; D Boumpas; R Brey; R Cervera; A Doria; D Jayne; M A Khamashta; A Kuhn; C Gordon; M Petri; O P Rekvig; M Schneider; Y Sherer; Y Shoenfeld; J S Smolen; R Talarico; A Tincani; R F van Vollenhoven; M M Ward; V P Werth; L Carmona
Journal:  Ann Rheum Dis       Date:  2009-11-05       Impact factor: 19.103

9.  Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality.

Authors:  F Goldblatt; S Chambers; A Rahman; D A Isenberg
Journal:  Lupus       Date:  2009-07       Impact factor: 2.911

10.  Predictors of major infections in systemic lupus erythematosus.

Authors:  Guillermo Ruiz-Irastorza; Nerea Olivares; Ioana Ruiz-Arruza; Agustin Martinez-Berriotxoa; Maria-Victoria Egurbide; Ciriaco Aguirre
Journal:  Arthritis Res Ther       Date:  2009-07-15       Impact factor: 5.156

View more
  36 in total

1.  Brief Report: Trends in Hospitalizations Due to Acute Coronary Syndromes and Stroke in Patients With Systemic Lupus Erythematosus, 1996 to 2012.

Authors:  Maria G Tektonidou; Zhong Wang; Michael M Ward
Journal:  Arthritis Rheumatol       Date:  2016-11       Impact factor: 10.995

2.  Connective tissue diseases: The burden of serious infections in SLE.

Authors:  Jessica Widdifield; Sasha Bernatsky
Journal:  Nat Rev Rheumatol       Date:  2015-04-21       Impact factor: 20.543

3.  Interhospital variation in mortality among patients with systemic lupus erythematosus and sepsis in the USA.

Authors:  Maria G Tektonidou; Abhijit Dasgupta; Michael M Ward
Journal:  Rheumatology (Oxford)       Date:  2019-10-01       Impact factor: 7.580

4.  Clinical characteristics and risk factors of infections in patients with systemic lupus erythematosus.

Authors:  Chengcheng Hou; Ou Jin; Xi Zhang
Journal:  Clin Rheumatol       Date:  2018-07-09       Impact factor: 2.980

5.  Severe infections in systemic lupus erythematosus: disease pattern and predictors of infection-related mortality.

Authors:  C L Teh; S A Wan; G R Ling
Journal:  Clin Rheumatol       Date:  2018-04-18       Impact factor: 2.980

6.  Characteristics and risk factors of an emergency department visit in patients with systemic lupus erythematosus.

Authors:  Yoshiki Nagai; Naoto Yokogawa; Kota Shimada; Shoji Sugii
Journal:  Rheumatol Int       Date:  2019-07-15       Impact factor: 2.631

Review 7.  Infection Risk and Safety of Corticosteroid Use.

Authors:  Jameel Youssef; Shannon A Novosad; Kevin L Winthrop
Journal:  Rheum Dis Clin North Am       Date:  2015-10-24       Impact factor: 2.670

8.  Evaluation of a patient self-stratification methodology to identify those in need of shielding during COVID-19.

Authors:  Elizabeth Reilly; Sarah Skeoch; Sarah Hardcastle; John D Pauling; Megan Rowe; Tehseen Ahmed; Andrew Allard; Bashaar Boyce; Ellie Korendowych; Chloe Lapraik; William Tillett; Raj Sengupta
Journal:  Clin Med (Lond)       Date:  2020-09-11       Impact factor: 2.659

9.  Gut Microbiota in Human Systemic Lupus Erythematosus and a Mouse Model of Lupus.

Authors:  Xin M Luo; Michael R Edwards; Qinghui Mu; Yang Yu; Miranda D Vieson; Christopher M Reilly; S Ansar Ahmed; Adegbenga A Bankole
Journal:  Appl Environ Microbiol       Date:  2018-01-31       Impact factor: 4.792

10.  Systemic Lupus Erythematosus is a Risk Factor for Complications in Total Joint Arthroplasty.

Authors:  J Joseph Gholson; Brandon G Wilkinson; Timothy S Brown; Yubo Gao; S Blake Dowdle; John J Callaghan
Journal:  Iowa Orthop J       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.